Aclaris Therapeutics Inc (ACRS)
EBITDA Margin
-916.38%
TTM · Period ending:
ACRS EBITDA Margin
Latest reported-916.38%period ending
Latest reported-916.38%period ending
ACRS TTM EBITDA Margin (-8441.23% → -916.38%)
TTM ebitda margin
High-resolution chart · PNG
ACRS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -916.3767% | |
| -845.1416% | |
| -877.1659% | |
| -399.4473% | |
| -344.684% | |
| -300.8606% | |
| -276.262% | |
| -226.6691% | |
| -253.795% | |
| -324.3003% | |
| -369.775% | |
| -530.7484% | |
| -330.0372% | |
| -308.1% | |
| -283.5339% | |
| -353.4638% | |
| -1,364.3869% | |
| -1,127.2021% | |
| -953.424% | |
| -841.0088% | |
| -717.4811% | |
| -662.3614% | |
| -721.1663% | |
| -843.6051% | |
| -1,131.3506% | |
| -791.6578% | |
| -659.9045% | |
| -680.4859% | |
| -652.6939% | |
| -816.6048% | |
| -1,194.7478% | |
| -1,454.7096% | |
| -1,628.47% | |
| -3,190.1464% | |
| -4,235.7695% | |
| -8,441.2281% |